PLUS1
0.78
-0.04 (-4.88%)
-0.04 (-4.88%)
Upgrade to Real-Time
Market Closed
Low
0.75
High
3.53
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Aptose Biosciences Inc | APS | Toronto | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
|
|
|---|---|---|---|---|
| -0.04 | -4.88% | 0.78 | 15:10:13 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.78 | 0.78 | 0.78 | 0.78 | 0.82 |
| Trades | Stocks Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 5 | 2,818 | - | 0.75 - 3.53 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:27:49 | 200 | $ 0.81 | CAD |
Period:
Draw Mode:
Aptose Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 75.68M | 91.04M | 91.04M | $ - | $ 0.00 | -0.92 | -1.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 1.06M | $ - | - | 1.61M | 1.40% |
Aptose Biosciences News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/04/2022 | 07:22 | Dow Jones News | Aptose Gets FDA Fast-Track Designation for HM43239 |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.83 | 0.84 | 0.75 | 0.7776836 | 6,123 | -0.05 | -6.02% |
| 1 Month | 1.04 | 1.05 | 0.75 | 0.9107324 | 16,572 | -0.26 | -25.0% |
| 3 Months | 1.10 | 1.16 | 0.75 | 0.9867833 | 12,749 | -0.32 | -29.09% |
| 6 Months | 1.77 | 1.92 | 0.75 | 1.25 | 17,911 | -0.99 | -55.93% |
| 1 Year | 2.96 | 3.53 | 0.75 | 1.85 | 37,785 | -2.18 | -73.65% |
| 3 Years | 2.95 | 12.62 | 0.75 | 5.96 | 52,001 | -2.17 | -73.56% |
| 5 Years | 1.82 | 12.62 | 0.75 | 5.15 | 45,818 | -1.04 | -57.14% |
Aptose Biosciences Description
| Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. |
